Section Arrow
MBIO.NASDAQ
- Mustang Bio
(Financial Status)
Quotes are at least 15-min delayed:2024/05/16 02:43 EDT
Last
 0.2765
+0.0079 (+2.94%)
Day High 
0.282 
Prev. Close
0.2686 
1-M High
0.52 
Volume 
79.98K 
Bid
0.2633
Ask
0.28
Day Low
0.265 
Open
0.282 
1-M Low
0.22 
Market Cap 
3.36M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.28 
20-SMA 0.3 
50-SMA 0.68 
52-W High 8.17 
52-W Low 0.22 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.00/-6.58
Enterprise Value
5.34M
Balance Sheet
Book Value Per Share
0.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 02:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipelineis currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.